Your browser doesn't support javascript.
loading
Loss of Heterozygosity of BRCA1/2 as a Predictive Marker for Talazoparib Response.
Mizrahi, Avital Granit; Hamad, Haneen; Gugenheim, Ahinoam; Nisman, Benjamin; Kuznetz, Anna; David, Inna Ben; Gelfend, Yael; Cohen, Sherri; Zick, Aviad; Sheva, Kim; Nechushtan, Hovav; Peretz, Tamar; Meirovitz, Amichay.
Afiliação
  • Mizrahi AG; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Hamad H; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Gugenheim A; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Nisman B; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Kuznetz A; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • David IB; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Gelfend Y; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Cohen S; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Zick A; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Sheva K; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
  • Nechushtan H; Faculty of Medicine, Hebrew University, Jerusalem, Israel.
  • Peretz T; The Legacy Heritage Oncology Center and Dr. Larry Norton Institute, Soroka University Medical Center, Be'er Sheva, Israel.
  • Meirovitz A; Oncology Laboratory, Sharett Institute of Oncology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Anticancer Res ; 42(11): 5257-5263, 2022 Nov.
Article em En | MEDLINE | ID: mdl-36288893
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribose / Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ribose / Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Anticancer Res Ano de publicação: 2022 Tipo de documento: Article